Chemistry:Ablukast

Short description: Chemical compound

Ablukast

Clinical data
ATC code	none
Legal status
Legal status	Investigational
Identifiers
IUPAC name 6-acetyl-7-[5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentoxy]chroman-2-carboxylic acid
CAS Number	96566-25-5
PubChem CID	57109
ChemSpider	51496 Y
UNII	000TKM5BBQ
KEGG	D02739 Y
ChEMBL	ChEMBL22016 Y
Chemical and physical data
Formula	C28H34O8
Molar mass	498.572 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCCOC2=CC3=C(CCC(O3)C(=O)O)C=C2C(=O)C
InChI InChI=1S/C28H34O8/c1-4-8-21-23(12-10-20(17(2)29)27(21)31)34-13-6-5-7-14-35-26-16-25-19(15-22(26)18(3)30)9-11-24(36-25)28(32)33/h10,12,15-16,24,31H,4-9,11,13-14H2,1-3H3,(H,32,33) Y Key:FGGYJWZYDAROFF-UHFFFAOYSA-N Y
(verify)

Ablukast (INN) is an experimental drug that is a leukotriene antagonist. It was investigated for potential applications in the treatment of inflammatory conditions, including asthma, skin disorders, and inflammatory bowel disease. It reached Phase III clinical trials, but development was discontinued in 1996.